Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 64 ROC (Joel Greenblatt) % is 14.40% as of Feb. 2026, which is 3% above its 10-year median of 13.94. GuruFocus rates TSE:3353 with a GF Score™ of 64/100 and a GF Value™ of 円3,554.57 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 562 Conglomerates companies, Medical Ikkou Group Co ranks better than 50.89% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Medical Ikkou Group Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 14.40%.
The historical rank and industry rank for Medical Ikkou Group Co's ROC (Joel Greenblatt) % or its related term are showing as below:
TSE:3353'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 10.54 Med: 13.94 Max: 18.39
Current: 15.06
During the past 13 years, Medical Ikkou Group Co's highest ROC (Joel Greenblatt) % was 18.39%. The lowest was 10.54%. And the median was 13.94%.
TSE:3353's ROC (Joel Greenblatt) % is ranked better than 50.89% of 562
companies
in the Conglomerates industry
Industry Median: 14.68
vs TSE:3353: 15.06
Medical Ikkou Group Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 4.60% per year.
Medical Ikkou Group Co (TSE:3353) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Medical Ikkou Group Co ROC (Joel Greenblatt) % Related Terms
Medical Ikkou Group Co ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Medical Ikkou Group Co's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co ROC (Joel Greenblatt) % Chart
TSE:3353 vs MMM, HON: ROC (Joel Greenblatt) % Comparison
For the Conglomerates subindustry, Medical Ikkou Group Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co ROC (Joel Greenblatt) % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's ROC (Joel Greenblatt) % falls into.
Medical Ikkou Group Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Feb. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 14.40% mean?
Medical Ikkou Group Co (TSE:3353) has a ROC (Joel Greenblatt) % of 14.40% as of Feb. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medical Ikkou Group Co and its competitors. This is near median its historical median of 13.94. Over the past decade, Medical Ikkou Group Co's ROC (Joel Greenblatt) % has ranged from 10.54 to 18.39. According to the industry distribution chart, Medical Ikkou Group Co ranks #276 out of 562 companies in the Conglomerates industry, placing it in the top 49.1%.
Is Medical Ikkou Group Co's ROC (Joel Greenblatt) % too high?
Medical Ikkou Group Co's current ROC (Joel Greenblatt) % of 14.40% is near median its 10-year median of 13.94. Over the past 10 years, this metric has ranged from a low of 10.54 to a high of 18.39. The Conglomerates industry median ROC (Joel Greenblatt) % is 14.68. Medical Ikkou Group Co's value of 14.40% is 1.9% below this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #276 out of 562 companies in the Conglomerates industry, which is above the industry midpoint. Overall, Medical Ikkou Group Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's ROC (Joel Greenblatt) % compare to MMM and HON?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #276 out of 562 companies for ROC (Joel Greenblatt) %. This puts Medical Ikkou Group Co in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 14.68. Medical Ikkou Group Co's value of 14.40% is 1.9% below this benchmark. Historically, Medical Ikkou Group Co's own ROC (Joel Greenblatt) % has ranged from 10.54 to 18.39 over the past decade. While the company's 10-year median is 13.94 vs. the industry median of 14.68, Medical Ikkou Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Conglomerates company?
The median ROC (Joel Greenblatt) % among Conglomerates companies is 14.68, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current ROC (Joel Greenblatt) % of 14.40% is 1.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median ROC (Joel Greenblatt) % is 14.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current ROC (Joel Greenblatt) % is 14.40%, which is near median its own 10-year median of 13.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,554.57, compared to a current price of 円2,830.00 — trading 20.4% below its estimated fair value. The current ROC (Joel Greenblatt) % is 14.40%, which is near median its 10-year median of 13.94 and 1.9% below the Conglomerates industry median of 14.68. Medical Ikkou Group Co's overall GF Score™ is 64/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current ROC (Joel Greenblatt) % is 14.40% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,830.00 is trading 20.4% below its estimated GF Value™ of 円3,554.57.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
ROC (Joel Greenblatt) %: 14.40% (near median its 10-year median of 13.94)
GF Value™: 円3,554.57 vs. price of 円2,830.00 (20.4% below fair value)
Industry Position: 1.9% below the Conglomerates median (#276 of 562)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
64GF Score
Get the complete analysis for TSE:3353
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
